Rate Control in Patients With Atrial Fibrillation

Not Applicable

• Conditions: Rate Control; Cardiopulmonary Exercise Test; Atrial Fibrillation
• Interventions: Drug: Atenolol, Bisoprolol, Metoprolol, Nebivolol, Propranolol, Diltiazem, Verapamil, digoxin

• Registration Number: NCT04513509
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

To search for the best marker for the patients in atrial fibrillation with rate control

Detailed Description

In an aging society, the prevalence of atrial fibrillation is increasing. The main treatment strategy is to reduce the complications of embolic stroke and heart failure. Among these patients, a group of them will choose to have "rate control" based on the heart conditions and the preference of the patients. The strategy is to control the ventricular rate by drugs to prevent the heart from failure. However, when the physicians attempt to do so, they encounter two questions: how much is the optimal drug dose? And what is the best marker we are looking to? To answer these questions, the investigators design a prospective, cross-over study to explore this issue. The participants will do cardiopulmonary exercise test (CPET) before and after treatment. They will receive another CPET if drug dose is titrated up. With the study, the investigators will understand whether a resting heart rate can be a good marker for optimal drug dosage, and what is the optimal range of heart rate the physicians should target.

Study Timeline

• Status Verified: 2020-08
• Study Start: 2020-08-07
• Study First Submitted: 2020-08-09
• Study First Submitted QC: 2020-08-12
• Study First Posted: 2020-08-14
• Last Update Submitted: 2020-08-16
• Last Update Posted: 2020-08-18
• Primary Completion: 2022-06-30
• Study Completion: 2022-06-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. 20~90 years old
2. Rate control is preferred after shared decision making

Read More

Exclusion Criteria

1. cannot cooperate with or complete CPET
2. has contraindication for CPET, such as uncontrolled heart failure, hypertension, angina, valvular heart disease, lung function impariment that SaO2<90% at room air.
3. Ventricular rate below 80/min before any medication
4. Permanent pacemaker implanted

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SEQUENTIAL

Arm && Interventions

Group	Intervention	Description
rate control	Atenolol, Bisoprolol, Metoprolol, Nebivolol, Propranolol, Diltiazem, Verapamil, digoxin	-

Primary Outcome Measures

Name	Time	Method
Change of Maximal Oxygen consumption	0, 3, 6 months	acquire the data by Cardiopulmonary exercise test (CPET) with different (low and high) drug dosages for rate control

Trial Locations

Locations (1)

National Taiwan University Hospital; 🇨🇳 Taipei, Taiwan